Trials / Unknown
UnknownNCT02258282
Safety and Efficacy of Etanercept in Patients With Psoriasis
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Chengdu PLA General Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate safety and efficacy of etanercept in patients with psoriasis who had an unsatisfactory response to traditional DMARDs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Etanercept | |
| DRUG | Control |
Timeline
- Start date
- 2014-05-01
- Primary completion
- 2022-12-01
- Completion
- 2022-12-01
- First posted
- 2014-10-07
- Last updated
- 2017-04-04
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02258282. Inclusion in this directory is not an endorsement.